Position in ACLX
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$7,107,931
-$1,401,970 QoQ
Shares Held
61,905
-52.6% QoQ
Ownership
0.106%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Russell Investments Group, Ltd. holds $1,223,802,944 across 266 Biotechnology names. ACLX ranks #38 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
228,086 | $176,228,356 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
367,691 | $164,188,731 | |
| 3 | RPRX |
Royalty Pharma plc
|
1,397,958 | $67,060,041 | |
| 4 | INCY |
Incyte Corp
|
638,242 | $60,071,331 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
147,533 | $48,814,236 | |
| 6 | MRNA |
Moderna, Inc.
|
710,640 | $36,100,509 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
606,224 | $34,245,589 | |
| 8 | INSM |
INSMED Inc
|
169,162 | $27,661,365 |
All Filings in ACLX
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,107,931 | 61,905 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $8,509,901 | 130,520 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $11,784,140 | 143,534 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $8,433,078 | 128,065 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $9,972,707 | 152,023 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $20,659,209 | 269,386 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $26,779,149 | 320,670 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $13,002,266 | 235,591 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $13,592,643 | 195,437 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $10,519,580 | 189,542 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $6,398,910 | 178,342 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,678,733 | 116,342 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $1,544,566 | 50,132 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $760,341 | 24,543 | Shares | Sole | 2023-02-08 | |
| No filing history on record for this holder in this stock. | ||||||